HQY today
$103.03-$0.51 (-0.49%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourSymmetric Triangle
1 hourDescending Triangle
15 minAscending Triangle
5 minAscending Triangle
Daily trend turns down below $100.55
Key levels
Resistance$110.26
Resistance$105.55
Support$100.54
Support$93.96
Latest news & SEC filings
DealHarvard Pilgrim Health Care adds HealthEquity lifestyle spending accounts
AnalystBMO Capital keeps Outperform rating on HealthEquity, lifts target to $125
SEC FilingHealthequity, Inc. filed an insider trading report (Form 4)
All HQY news →About HealthEquity
HealthEquity provides technology-based services for consumer-directed healthcare accounts. It administers health savings accounts, flexible spending accounts, health reimbursement arrangements, COBRA continuation coverage, and commuter benefits for employers and their workers. The company also offers payment processing, benefit information, an investment platform with advisory options, and a marketplace for healthcare products and services. It operates in the United States, reaching consumers mainly through employers, benefits brokers, and partnerships with health plans and administrators.
Based on the company's 10-K filed Mar 17, 2026.
Nasdaq · Industrials
HEALTHEQUITY, INC. (HQY)
What Is the Price Target for HQY?
SEPT Low Target
$108.00
SEPT Mid Target
$115.00
SEPT High Target
$142.00
Analyst Consensus
$115.00
Is HQY a Buy or Sell Right Now?
Thesis
- •Revenue growing 9.5% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HQY.
Start Free Trial →Is HQY Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$110.28
65
Moat Score
NARROW
9/9
Piotroski Score
5.2
Altman Z-Score
What Is Smart Money Doing with HQY?
Insider Signal
SELLING
0 buys / 5 sells (90d)
Congress Signal
BUYING
4 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Gathright Michael | officer | Sale | 662 | $60K | Oct 6, 2026 |
| Fiore Michael Henry | other | Sale | 2,032 | $185K | Oct 6, 2026 |
| Cutler Scott | director officer | Sale | 1,230 | $112K | Oct 6, 2026 |
| Ladd Delano | officer | Sale | 1,080 | $98K | Oct 6, 2026 |
| Lucania James M | officer | Sale | 2,822 | $257K | Oct 6, 2026 |
| Neeleman Stephen | director officer | Sale | 1,095 | $100K | Oct 6, 2026 |
| Neeleman Stephen | director officer | Sale | 1,500 | - | Sep 17, 2026 |
| DILLON ADRIAN T | director | Buy | 7,632 | $248K | Aug 25, 2026 |
| DILLON ADRIAN T | director | Sale | 6,300 | $658K | Aug 25, 2026 |
| DILLON ADRIAN T | director | Sale | 1,332 | $140K | Aug 25, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HQY Growth Story
Revenue YoY
9.5%
3yr Revenue CAGR
15.1%
EPS Growth YoY
125.69%
FCF Growth YoY
34.7%
Revenue Trend
STRONG
Dark Pool Trades for HQY
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HQY, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:13:16 | $103.03 | 2,070 | $$213K | BUY |
| 21:00:12 | $103.03 | 1,090 | $$112K | BUY |
| 19:10:25 | $103.02 | 1,052 | $$108K | SELL |
| 17:21:56 | $102.10 | 5,616 | $$573K | SELL |
| 17:14:40 | $102.23 | 1,299 | $$133K | BUY |
5 dark pool trades shown · $$1.1M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for HEALTHEQUITY, INC. (HQY) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HQY — frequently asked questions
What is HQY stock price today?
HEALTHEQUITY, INC. (HQY) is at $103.03, down 0.49% (-$0.51) at the Nov 11, 2026 close.
Why is HQY stock moving today?
Latest HQY news — Oct 28, 2026: Harvard Pilgrim Health Care adds HealthEquity lifestyle spending accounts · Oct 21, 2026: BMO Capital keeps Outperform rating on HealthEquity, lifts target to $125
What is the HQY price target?
The average analyst price target for HQY is $115.00, ranging from $108 to $142, based on 6 analysts. Latest: BMO Capital maintains on Oct 21, 2026.
What do analysts rate HQY?
Analyst ratings for HQY: 1 Buy, 7 Hold, 0 Sell — consensus Hold.
Did HQY beat earnings?
HQY last reported on Aug 27, 2026: EPS $1.24 vs $1.19 expected — a beat of 4.2%.
What is HQY's P/E ratio?
HQY trades at a P/E of 36.8 vs a Industrials average of 25.8.
Does HQY pay a dividend?
HQY does not currently pay a dividend.
How much debt does HQY have?
HEALTHEQUITY, INC. reported $931M of debt and $256M of cash (Jul 31, 2026).
What are HQY support and resistance levels?
Support: $100.54, $93.96, $89.08. Resistance: $105.55, $110.26, $116.65.
What are insiders doing with HQY?
Insider activity: SELLING, 0 buys and 5 sells in the last 90 days.
What is the latest news on HQY?
Oct 28, 2026: Harvard Pilgrim Health Care adds HealthEquity lifestyle spending accounts · Oct 21, 2026: BMO Capital keeps Outperform rating on HealthEquity, lifts target to $125 · Oct 19, 2026: Healthequity, Inc. filed an insider trading report (Form 4)